• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.

作者信息

Ma Huan, Zhao Dan, Zeng Weihong, Yang Yunru, Hu Xiaowen, Zhou Peigen, Weng Jianping, Cheng Linzhao, Zheng Xueying, Jin Tengchuan

机构信息

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.

Hefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.

出版信息

Sci China Life Sci. 2021 Mar;64(3):482-485. doi: 10.1007/s11427-020-1805-0. Epub 2020 Aug 28.

DOI:10.1007/s11427-020-1805-0
PMID:32876887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463100/
Abstract
摘要

相似文献

1
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.康复期新冠患者出院后100天内SARS-CoV-2特异性IgG、IgM和IgA水平下降
Sci China Life Sci. 2021 Mar;64(3):482-485. doi: 10.1007/s11427-020-1805-0. Epub 2020 Aug 28.
2
SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.严重急性呼吸综合征冠状病毒 2 型抗体：IgA 与 COVID-19 感染早期疾病的严重程度相关。
J Med Virol. 2021 Sep;93(9):5409-5415. doi: 10.1002/jmv.27058. Epub 2021 May 12.
3
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.用于特异性 SARS-CoV-2 IgG、IgA 和 IgM 抗体的 ELISA 的分析和临床验证。
J Med Virol. 2021 Feb;93(2):803-811. doi: 10.1002/jmv.26303. Epub 2020 Jul 27.
4
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.比较分析来自人类血清样本的 SARS-CoV-2 结合抗体（IgG、IgM、IgA）和中和抗体。
J Immunol Methods. 2021 Feb;489:112937. doi: 10.1016/j.jim.2020.112937. Epub 2020 Nov 28.
5
Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.对 COVID-19 恢复期患者体内 SARS-CoV-2 抗体反应的特征描述。
J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.
6
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.COVID-19 患者在疫情早期对 SARS-CoV-2 抗体的动态变化。
Virol Sin. 2020 Dec;35(6):744-751. doi: 10.1007/s12250-020-00268-5. Epub 2020 Jul 27.
7
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
8
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma.是否忽视了 IgA？对 2019 冠状病毒病康复期血浆的再审视。
Transfusion. 2021 Jun;61(6):1740-1748. doi: 10.1111/trf.16435. Epub 2021 May 26.
9
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.住院 COVID-19 患者的早期 IgG/IgA 反应与疾病的严重程度较轻有关。
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115586. doi: 10.1016/j.diagmicrobio.2021.115586. Epub 2021 Oct 23.
10
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.急危重症高血压患者的 SARS-CoV-2 特异性动态免疫。
Front Immunol. 2020 Dec 10;11:596684. doi: 10.3389/fimmu.2020.596684. eCollection 2020.

引用本文的文献

1
Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough.中和抗体测试支持在SARS-CoV-2奥密克戎突破感染后对年轻人采取加强免疫策略。
Eur J Med Res. 2025 Jan 6;30(1):7. doi: 10.1186/s40001-024-02240-5.
2
Profiling of Early Immune Responses to Vaccination Using THP-1-Derived Dendritic Cells.使用 THP-1 来源的树突状细胞对疫苗接种的早期免疫应答进行分析。
Int J Mol Sci. 2024 May 18;25(10):5509. doi: 10.3390/ijms25105509.
3
Immunological survey of COVID-19 among medicos of tribal preponderant state of India.印度部落人口占优势邦的医务人员中新冠病毒病的免疫学调查
J Family Med Prim Care. 2023 Aug;12(8):1669-1672. doi: 10.4103/jfmpc.jfmpc_272_23. Epub 2023 Aug 29.
4
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Responses After Community Infections in Children and Adults.儿童和成人社区感染后针对严重急性呼吸综合征冠状病毒2的中和抗体反应
Open Forum Infect Dis. 2023 Mar 28;10(5):ofad168. doi: 10.1093/ofid/ofad168. eCollection 2023 May.
5
Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.新型冠状病毒肺炎患者血清中新型冠状病毒2抗体水平的动态变化
J Infect. 2022 Jul;85(1):90-122. doi: 10.1016/j.jinf.2022.04.032. Epub 2022 Apr 21.
6
Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.新型冠状病毒 IgG 抗体与 COVID-19 患者维生素 D 和炎症标志物的关系。
Sci Rep. 2022 Apr 5;12(1):5699. doi: 10.1038/s41598-022-09785-7.
7
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies.抗 SARS-CoV-2 IgG 抗体的长期持久性。
Curr Microbiol. 2022 Feb 12;79(4):96. doi: 10.1007/s00284-022-02800-0.
8
A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2.一位 48 岁免疫功能正常的佛罗里达州南部居民，经确认感染了 SARS-CoV-2 的 P.1（伽马）变体。
Am J Case Rep. 2022 Jan 18;23:e935329. doi: 10.12659/AJCR.935329.
9
The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland.波兰医护人员组的研究表明，康复者和未感染过新冠病毒的人接种mRNA疫苗后抗SARS-CoV-2抗体水平的差异在第二剂接种后消失。
Vaccines (Basel). 2021 Nov 27;9(12):1402. doi: 10.3390/vaccines9121402.
10
Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity.新冠病毒感染患者的再次感染：病毒基因变异性和宿主免疫的影响
Vaccines (Basel). 2021 Oct 12;9(10):1168. doi: 10.3390/vaccines9101168.